Buyout firm EQT to acquire Qiagen for $10.8 billion
QGEN•Qiagen said EQT would acquire it for about €9.6 billion ($10.78 billion). EQT offered €46.50 ($52.22) per share, an 8.6% premium to Qiagen’s last close.
1. Acquisition offer
Molecular testing company Qiagen said Swedish buyout firm EQT would acquire it for about €9.6 billion ($10.78 billion). EQT offered €46.50 ($52.22) per share, representing an 8.6% premium to Qiagen’s last close.
2. Sector context
The buyout ends years of takeover speculation surrounding the European diagnostics firm. Growing demand for molecular testing has made companies in the sector attractive acquisition targets for private-equity firms.
